Skip to main content

Table 3 Results of molecular docking

From: A novel microbial and hepatic biotransformation-integrated network pharmacology strategy explores the therapeutic mechanisms of bioactive herbal products in neurological diseases: the effects of Astragaloside IV on intracerebral hemorrhage as an example

Compounds

Targets

Binding energy (kcal/mol)

Hydrogen bonds

Hydrophobic interactions

CA

CDC42 (4js0)

− 7.5

Asp11, Asp11, Ser88, Asn92, Gln116

–

CA

PTK2 (6i8z)

− 7.3

Lys485, Leu486, Ser555, Lys-561

Tyr415, Leu449, Lys485, Ile487, Ile487, Glu500

CA

CSF1R (7mfc)

− 7.9

Asp670, Arg801, Arg801, Asp806, Asn808

Leu672, Arg782, Phe797, Arg801

Iso-CA

CSF1R (7mfc)

− 8.0

Asp670, Arg801, Arg801, Asn808

Leu672, Arg782, Phe797, Arg801